ALT
Price
$8.25
Change
+$0.07 (+0.86%)
Updated
Dec 20 closing price
94 days until earnings call
PRTA
Price
$15.22
Change
-$0.79 (-4.93%)
Updated
Dec 20 closing price
52 days until earnings call
Ad is loading...

ALT vs PRTA

Header iconALT vs PRTA Comparison
Open Charts ALT vs PRTABanner chart's image
Altimmune
Price$8.25
Change+$0.07 (+0.86%)
Volume$4.9M
CapitalizationN/A
Prothena
Price$15.22
Change-$0.79 (-4.93%)
Volume$1.56M
CapitalizationN/A
ALT vs PRTA Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. PRTA commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and PRTA is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ALT: $8.25 vs. PRTA: $15.22)
Brand notoriety: ALT and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 141% vs. PRTA: 271%
Market capitalization -- ALT: $587.85M vs. PRTA: $818.97M
ALT [@Biotechnology] is valued at $587.85M. PRTA’s [@Biotechnology] market capitalization is $818.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, ALT is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while PRTA’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 4 bearish.
  • PRTA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ALT and PRTA are a good buy in the short-term.

Price Growth

ALT (@Biotechnology) experienced а -8.64% price change this week, while PRTA (@Biotechnology) price change was +19.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.22%. For the same industry, the average monthly price growth was -1.31%, and the average quarterly price growth was +0.77%.

Reported Earning Dates

ALT is expected to report earnings on Mar 27, 2025.

PRTA is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (-2.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($819M) has a higher market cap than ALT($588M). ALT YTD gains are higher at: -26.667 vs. PRTA (-58.118). ALT has higher annual earnings (EBITDA): -103.19M vs. PRTA (-167.23M). PRTA has more cash in the bank: 519M vs. ALT (139M). ALT has less debt than PRTA: ALT (1.77M) vs PRTA (11.5M). PRTA has higher revenues than ALT: PRTA (133M) vs ALT (52K).
ALTPRTAALT / PRTA
Capitalization588M819M72%
EBITDA-103.19M-167.23M62%
Gain YTD-26.667-58.11846%
P/E RatioN/AN/A-
Revenue52K133M0%
Total Cash139M519M27%
Total Debt1.77M11.5M15%
FUNDAMENTALS RATINGS
ALT vs PRTA: Fundamental Ratings
ALT
PRTA
OUTLOOK RATING
1..100
7387
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
7492
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
4564
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
18n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRTA's Valuation (61) in the Biotechnology industry is somewhat better than the same rating for ALT (97) in the Miscellaneous Commercial Services industry. This means that PRTA’s stock grew somewhat faster than ALT’s over the last 12 months.

ALT's Profit vs Risk Rating (74) in the Miscellaneous Commercial Services industry is in the same range as PRTA (92) in the Biotechnology industry. This means that ALT’s stock grew similarly to PRTA’s over the last 12 months.

PRTA's SMR Rating (95) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that PRTA’s stock grew similarly to ALT’s over the last 12 months.

ALT's Price Growth Rating (45) in the Miscellaneous Commercial Services industry is in the same range as PRTA (64) in the Biotechnology industry. This means that ALT’s stock grew similarly to PRTA’s over the last 12 months.

PRTA's P/E Growth Rating (94) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that PRTA’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTPRTA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X95104.940000-2119.789000
-2.18%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with KRYS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+0.86%
KRYS - ALT
45%
Loosely correlated
+2.49%
CLDX - ALT
44%
Loosely correlated
-0.95%
PLRX - ALT
42%
Loosely correlated
-0.68%
INZY - ALT
42%
Loosely correlated
+6.41%
AXSM - ALT
42%
Loosely correlated
+1.10%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
-4.93%
DNLI - PRTA
46%
Loosely correlated
-0.19%
BEAM - PRTA
45%
Loosely correlated
+8.04%
NAUT - PRTA
42%
Loosely correlated
-2.22%
NTLA - PRTA
41%
Loosely correlated
+0.83%
ALT - PRTA
41%
Loosely correlated
+0.86%
More